MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 265 filers reported holding MYRIAD GENETICS INC in Q4 2018. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $361,000 | -94.8% | 18,264 | -96.6% | 0.00% | -90.9% |
| Q3 2020 | $6,966,000 | -27.1% | 534,218 | -36.6% | 0.01% | -38.9% |
| Q2 2020 | $9,560,000 | +1432.1% | 843,000 | +3581.2% | 0.02% | +1700.0% |
| Q4 2019 | $624,000 | -88.1% | 22,900 | -80.0% | 0.00% | -91.7% |
| Q3 2018 | $5,264,000 | +780.3% | 114,429 | +615.2% | 0.01% | +1100.0% |
| Q2 2018 | $598,000 | -28.4% | 16,000 | -43.4% | 0.00% | -50.0% |
| Q1 2018 | $835,000 | -57.7% | 28,248 | -50.9% | 0.00% | -60.0% |
| Q4 2017 | $1,975,000 | – | 57,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |